Macquarie Group’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-22,269
| Closed | -$49K | – | 2658 |
|
|
2021
Q3 | $49K | Sell |
22,269
-3,993,635
| -99% | -$10.9M | ﹤0.01% | 2246 |
|
|
2021
Q2 | $15.1M | Buy |
4,015,904
+73,320
| +2% | +$255K | 0.01% | 843 |
|
|
2021
Q1 | $12.9M | Buy |
3,942,584
+1,053,185
| +36% | +$3.78M | 0.02% | 658 |
|
|
2020
Q4 | $9.85M | Sell |
2,889,399
-393,274
| -12% | -$1.62M | 0.01% | 704 |
|
|
2020
Q3 | $13.4M | Buy |
3,282,673
+51,269
| +2% | +$195K | 0.02% | 574 |
|
|
2020
Q2 | $10.9M | Buy |
3,231,404
+231,840
| +8% | +$676K | 0.02% | 611 |
|
|
2020
Q1 | $6.99M | Buy |
2,999,564
+250,860
| +9% | +$687K | 0.01% | 638 |
|
|
2019
Q4 | $10M | Sell |
2,748,704
-639,483
| -19% | -$5.17M | 0.01% | 651 |
|
|
2019
Q3 | $28.1M | Buy |
3,388,187
+437,829
| +15% | +$3.54M | 0.05% | 382 |
|
|
2019
Q2 | $25.4M | Buy |
2,950,358
+196,320
| +7% | +$1.76M | 0.04% | 401 |
|
|
2019
Q1 | $29.4M | Buy |
2,754,038
+377,480
| +16% | +$4.04M | 0.05% | 375 |
|
|
2018
Q4 | $20.8M | Buy |
2,376,558
+1,119,715
| +89% | +$14.3M | 0.04% | 413 |
|
|
2018
Q3 | $21.1M | Buy |
1,256,843
+399,735
| +47% | +$8.65M | 0.03% | 465 |
|
|
2018
Q2 | $18M | Buy |
857,108
+411,938
| +93% | +$7.63M | 0.03% | 504 |
|
|
2018
Q1 | $7.16M | Buy |
445,170
+9,304
| +2% | +$184K | 0.01% | 682 |
|
|
2017
Q4 | $8.26M | Sell |
435,866
-1,043,647
| -71% | -$18.9M | 0.01% | 677 |
|
|
2017
Q3 | $20.8M | Sell |
1,479,513
-767,980
| -34% | -$6.95M | 0.04% | 446 |
|
|
2017
Q2 | $16.7M | Buy |
2,247,493
+193,883
| +9% | +$1.27M | 0.03% | 489 |
|
|
2017
Q1 | $13.3M | Buy |
2,053,610
+252,941
| +14% | +$1.41M | 0.02% | 544 |
|
|
2016
Q4 | $7.98M | Buy |
1,800,669
+69,087
| +4% | +$290K | 0.02% | 645 |
|
|
2016
Q3 | $8.09M | Sell |
1,731,582
-1,573,514
| -48% | -$9.32M | 0.02% | 648 |
|
|
2016
Q2 | $21.7M | Buy |
3,305,096
+2,009,407
| +155% | +$14.2M | 0.02% | 548 |
|
|
2016
Q1 | $8.24M | Buy |
1,295,689
+165,365
| +15% | +$849K | 0.02% | 602 |
|
|
2015
Q4 | $6.82M | Buy |
1,130,324
+95,895
| +9% | +$548K | 0.01% | 640 |
|
|
2015
Q3 | $6.19M | Buy |
1,034,429
+212,316
| +26% | +$1.47M | 0.01% | 664 |
|
|
2015
Q2 | $5.62M | Buy |
822,113
+124,215
| +18% | +$789K | 0.01% | 713 |
|
|
2015
Q1 | $4.24M | Buy |
697,898
+215,678
| +45% | +$1.43M | 0.01% | 794 |
|
|
2014
Q4 | $3.34M | Buy |
482,220
+75,758
| +19% | +$557K | 0.01% | 859 |
|
|
2014
Q3 | $3.31M | Buy |
406,462
+89,376
| +28% | +$699K | 0.01% | 837 |
|
|
2014
Q2 | $2.58M | Buy |
317,086
+37,635
| +13% | +$286K | 0.01% | 950 |
|
|
2014
Q1 | $2.19M | Buy |
279,451
+73,140
| +35% | +$619K | ﹤0.01% | 989 |
|
|
2013
Q4 | $1.83M | Buy |
206,311
+19,400
| +10% | +$173K | ﹤0.01% | 1024 |
|
|
2013
Q3 | $1.57M | Sell |
186,911
-7,120
| -4% | -$57.6K | ﹤0.01% | 1038 |
|
|
2013
Q2 | $1.45M | Buy |
+194,031
| New | +$1.49M | ﹤0.01% | 1053 |
|
Other funds holding SPPI
AC
Macquarie Group's SPPI Position: Q4 2021 in Review
Macquarie Group sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2021, closing a stake of 22,269 shares — an estimated $49K sold.
Macquarie Group first reported a position in SPPI in Q2 2013 and held it in 34 quarters. The position peaked at $29.4M in Q1 2019. 142 funds tracked by Wall St. Rank hold SPPI as of Q4 2021.
- Macquarie Group reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2021 after selling out during the quarter.
- Macquarie Group sold 22,269 Spectrum Pharmaceuticals Inc shares in Q4 2021, an estimated $49K.
- Macquarie Group first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 34 quarters.
- Macquarie Group's Spectrum Pharmaceuticals Inc position peaked at $29.4M in Q1 2019.
- 142 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2021.
Based on Macquarie Group's 13F filing for Q4 2021, filed 11 Feb 2022.